200 related articles for article (PubMed ID: 20144539)
1. Improving the data to strengthen the global response to HIV among people who inject drugs.
Mathers B; Cook C; Degenhardt L
Int J Drug Policy; 2010 Mar; 21(2):100-2. PubMed ID: 20144539
[TBL] [Abstract][Full Text] [Related]
2. How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia.
Bergenstrom A; McLeod R; Sharma M; Mesquita F; Dorabjee J; Atun R; Lewis G; Rao JV
Int J Drug Policy; 2010 Mar; 21(2):107-9. PubMed ID: 20144859
[TBL] [Abstract][Full Text] [Related]
3. Learning from HIV epidemics among injecting drug users.
Jarlais DC
Int J Drug Policy; 2010 Mar; 21(2):97-9. PubMed ID: 20018500
[TBL] [Abstract][Full Text] [Related]
4. Meth/amphetamine use and associated HIV: Implications for global policy and public health.
Degenhardt L; Mathers B; Guarinieri M; Panda S; Phillips B; Strathdee SA; Tyndall M; Wiessing L; Wodak A; Howard J;
Int J Drug Policy; 2010 Sep; 21(5):347-58. PubMed ID: 20117923
[TBL] [Abstract][Full Text] [Related]
5. The Global Fund's leadership on harm reduction: 2002-2009.
Atun R; Kazatchkine M
Int J Drug Policy; 2010 Mar; 21(2):103-6. PubMed ID: 20171865
[TBL] [Abstract][Full Text] [Related]
6. Global Fund investments in harm reduction from 2002 to 2009.
Bridge J; Hunter BM; Atun R; Lazarus JV
Int J Drug Policy; 2012 Jul; 23(4):279-85. PubMed ID: 22421551
[TBL] [Abstract][Full Text] [Related]
7. Islam and harm reduction.
Kamarulzaman A; Saifuddeen SM
Int J Drug Policy; 2010 Mar; 21(2):115-8. PubMed ID: 20006483
[TBL] [Abstract][Full Text] [Related]
8. The global diffusion of injecting drug use: implications for human immunodeficiency virus infection.
Stimson GV
Bull Narc; 1993; 45(1):3-17. PubMed ID: 8305905
[TBL] [Abstract][Full Text] [Related]
9. Injection drug use, HIV and the current response in selected low-income and middle-income countries.
Bergenstrom AM; Abdul-Quader AS
AIDS; 2010 Sep; 24 Suppl 3():S20-9. PubMed ID: 20926924
[TBL] [Abstract][Full Text] [Related]
10. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
[TBL] [Abstract][Full Text] [Related]
11. Drug injectors in Glasgow: a community at risk? A report from a multidisciplinary group. The Possilpark Group.
Health Bull (Edinb); 1993 Nov; 51(6):418-29. PubMed ID: 8307755
[TBL] [Abstract][Full Text] [Related]
12. Young people and drugs: next generation of harm reduction.
Merkinaite S; Grund JP; Frimpong A
Int J Drug Policy; 2010 Mar; 21(2):112-4. PubMed ID: 20036526
[TBL] [Abstract][Full Text] [Related]
13. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing a self-limiting HIV outbreak among ethnic Vietnamese injecting drug users in Melbourne, Australia.
Higgs P; Yohannes K; Hellard M; Maher L
Qual Health Res; 2009 Dec; 19(12):1690-701. PubMed ID: 19949219
[TBL] [Abstract][Full Text] [Related]
15. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
Lima ES; Bastos FI; Telles PR; Friedman SR
Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
[TBL] [Abstract][Full Text] [Related]
16. Moving from a project to programmatic response: scaling up harm reduction in Asia.
Chatterjee A; Sharma M
Int J Drug Policy; 2010 Mar; 21(2):134-6. PubMed ID: 20079618
[TBL] [Abstract][Full Text] [Related]
17. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
[TBL] [Abstract][Full Text] [Related]
18. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
Islam MM; Conigrave KM
Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
[TBL] [Abstract][Full Text] [Related]
19. Drug injecting and HIV infection among the population of drug abusers in Asia.
Poshyachinda V
Bull Narc; 1993; 45(1):77-90. PubMed ID: 8305908
[TBL] [Abstract][Full Text] [Related]
20. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.
Wodak A; Cooney A
Subst Use Misuse; 2006; 41(6-7):777-813. PubMed ID: 16809167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
